RUBRACA

This brand name is authorized in Austria, Estonia, Spain, France, Ireland, Israel, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug RUBRACA contains one active pharmaceutical ingredient (API):

1 Rucaparib
UNII 41AX9SJ8KO - RUCAPARIB CAMSYLATE

Rucaparib is an inhibitor of poly(ADP-ribose) polymerase (PARP) enzymes, including PARP-1, PARP-2, and PARP-3, which play a role in DNA repair. In vitro studies have shown that rucaparibinduced cytotoxicity involves inhibition of PARP enzymatic activity and the trapping of PARP-DNA complexes resulting in increased DNA damage, apoptosis, and cell death.

Read about Rucaparib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RUBRACA Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XK03 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
Discover more medicines within L01XK03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1773806, 1773817, 1773828
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171250001, 1171250002, 1171250003
Country: FR Base de données publique des médicaments Identifier(s): 60261656, 60980609, 69586252
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 358195, 358199, 358203
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8460, 8470, 8471
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085748, 1085749, 1085750
Country: NL Z-Index G-Standaard, PRK Identifier(s): 196916, 196924, 196932
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100418021, 100418038, 100418044
Country: US FDA, National Drug Code Identifier(s): 69660-201, 69660-202, 69660-203

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.